Allergan's sales of eye care pharmaceuticals rose by 6.6 percent...
Allergan's sales of eye care pharmaceuticals rose by 6.6 percent year-on-year to $603.4 million in the fourth quarter of 2010. At constant currency rates, turnover was up by 7.4 percent. The company's overall revenues rose by 6.9 percent, or by 7.4 percent on a currency-neutral basis, and reached $1.29 billion. ...
To continue reading this article register now.
Already an Eyewear Intelligence subscriber? Sign in here.
Become a member today for full access from just €7,29 a week!
Buying a membership today will give you:
- Unlimited access to ewintelligence.com - all insight and analysis available online
- Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Access to over 11,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Powerful search and intuitive navigation
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.